Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose ...
As national conversation behind the health effects of artificial dyes picks up, an Oklahoma lawmaker is looking to ban some ...
The FDA has updated the December recall of some of Cal Yee Farms' products to the highest risk level classification for three ...
Type 2 diabetes is a leading cause of chronic kidney disease, which affects more than 1 in 7 U.S. adults. The new approval ...
The U.S. Food and Drug Administration (FDA) approved the antidepressant nasal spray Spravato as a standalone treatment for depression in adults.
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. To ...